Garry Takle, Ph.D. has been appointed vice president of operations at WuXi AppTec, Inc., and Joseph Hughes, Ph.D. has been appointed vice president of testing services for the company’s Philadelphia facility. Both Dr. Takle and Dr. Hughes will report directly to Edward Hu, chief operating officer of WuXi PharmaTech.
   
Dr. Takle has been with the company for nine years in roles of increasing responsibility at the Philadelphia site, most recently as vice president of R&D testing. He has more than 20 years of experience in the biopharm/biotech industry and previously worked at Wellcome (now GSK UK), the Rockefeller University and Innovir. In his new position, Dr. Takle will focus on continuous improvements in operations at the Philadelphia facility and will have overall responsibility for biologics manufacturing services.
   
Dr. Hughes has been with the company for more than 10 years in various leadership capacities. He has more than 29 years of experience in the industry, including previous positions at Merck Sharp and Dohme Research Laboratories and at Sterling Winthrop. In his new position, Dr. Hughes will take on direct management of all of the testing laboratories at the Philadelphia facility and also work to expand the company’s biologics services and client base.
   
“WuXi AppTec is fortunate to have two such experienced and talented managers within our organization to tap for these important roles,” said Mr. Hu. “Their deep understanding of the industry, their many years with the company and their proven track record as leaders will be tremendous assets as the Philadelphia facility continues to grow and strengthen its services for the biologics industry.”